FrancophonIA/ELRC3.0 huggingface dataset:
English: Duloxetine Mylan should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent CYP1A2 inhibitors) since the combination results in elevated plasma concentrations of duloxetine (see section 4.5).
Slovenian: Zdravila Duloksetin Mylan ne smemo uporabljati v kombinaciji s fluvoksaminom, ciprofloksacinom ali enoksacinom (tj. močnimi zaviralci CYP1A2), saj kombinacija povzroči povišane plazemske koncentracije duloksetina (glejte poglavje 4.5).
English: What Duloxetine Mylan is and what it is used for
Slovenian: Kaj je zdravilo Duloksetin Mylan in za kaj ga uporabljamo
English: Biotransformation: Duloxetine is extensively metabolised and the metabolites are excreted principally in urine.
Slovenian: Duloksetin se obsežno presnavlja, presnovki se izločajo predvsem v urinu.
English: • coughing, wheezing and shortness of breath which may be accompanied by a high temperature
Slovenian: • kašelj, piskanje v pljučih in zadihanost, ki jih lahko spremlja visoka telesna temepratura
English: If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Slovenian: Če imate kakršna koli dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom ali farmacevtom.
English: Therefore, caution should be exercised when treating the elderly with the maximum dosage (see sections 4.2 and 5.2).
Slovenian: Pri zdravljenju starejših bolnikov je torej pri maksimalnem odmerjanju potrebna previdnost (glejte poglavji 4.2 in 5.2).
English: Based on the half-life of duloxetine, at least 5 days should be allowed after stopping Duloxetine Mylan before starting an MAOI (see section 4.3).
Slovenian: Na podlagi razpolovnega časa duloksetina pa mora po prenehanju jemanja zdravila Duloksetin Mylan preteči vsaj 5 dni pred začetkom jemanja MAOI (glejte poglavje 4.3).
English: As a general recommendation, caution should be exercised when treating the elderly (see sections 4.2 and 4.4).
Slovenian: V splošnem priporočamo previdnost pri zdravljenju starejših bolnikov (glejte poglavji 4.2 in 4.4).
English: Bottle packs only: Once opened, use within 180 days.
Slovenian: Po odprtju porabiti v 180 dneh.
English: • fainting, dizziness, lightheadedness or fainting on standing up, cold fingers and/or toes
Slovenian: • omedlevica, omotica, občutek omotičnosti ali omedlevice ob prehitrem vstajanju, hladni prsti rok in/ali nog
English: How to store Duloxetine Mylan Contents of the pack and other information
Slovenian: Shranjevanje zdravila Duloksetin Mylan Vsebina pakiranja in dodatne informacije
English: Duloxetine Mylan is used in adults to treat:
Slovenian: Zdravilo Duloksetin Mylan pri odraslih se uporablja za zdravljenje:
English: The most commonly reported adverse reactions in patients treated with duloxetine were nausea, headache, dry mouth, somnolence, and dizziness.
Slovenian: Neželeni učinki, o katerih so pri bolnikih, zdravljenih z duloksetinom, najpogosteje poročali, so bili slabost, glavobol suha usta, zaspanost in omotica.
English: Excipient(s) with known effect Each capsule contains 62.1 mg sucrose.
Slovenian: Pomožna snov z znanim učinkom Ena kapsula vsebuje 62,1 mg saharoze.
English: A total of 467 paediatric patients initially randomized to duloxetine in clinical trials, experienced a 0.1 kg mean decrease in weight at 10-weeks compared with a 0.9 kg mean increase in 353 placebo-treated patients.
Slovenian: Skupno 467 pediatričnih bolnikov, ki so bili v kliničnih študijah na začetku randomizirani za zdravljenje z duloksetinom, je v 10 tednih izgubilo 0,1 kg telesne mase (srednja vrednost), v primerjavi s povprečnim porastom 0,9 kg pri 353 bolnikih, ki so prejemali placebo.
English: Duloxetine may increase the risk of postpartum haemorrhage (see section 4.6).
Slovenian: Duloksetin lahko poveča tveganje za poporodno krvavitev (glejte poglavje 4.6).
English: Excipient(s) with known effect Each capsule contains 124.2 mg sucrose.
Slovenian: Pomožna snov z znanim učinkom Ena kapsula vsebuje 124,2 mg saharoze.
English: Major depressive disorder
Slovenian: Velike depresivne motnje
English: Each capsule of Duloxetine Mylan contains pellets of duloxetine hydrochloride with a covering to protect them from stomach acid.
Slovenian: Vsaka kapsula zdravila Duloksetin Mylan vsebuje pelete duloksetinijevega klorida z oblogo za zaščito pred želodčno kislino.
English: Absorption: Duloxetine is well absorbed after oral administration with a Cmax occurring 6 hours post dose.
Slovenian: Duloksetin se po peroralnem jemanju dobro absorbira s pojavom Cmax 6 ur po odmerjanju.
English: Inhibitors of CYP1A2: Because CYP1A2 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of CYP1A2 is likely to result in higher concentrations of duloxetine.
Slovenian: Ker je CYP1A2 vpleten v presnovo duloksetina, je verjetno, da bo sočasna uporaba duloksetina z močnimi zaviralci CYP1A2 povzročila višje koncentracije duloksetina.
English: • Make sure your midwife and/or doctor knows you are on Duloxetine Mylan.
Slovenian: • Medicinski sestri, babici in/ali zdravniku povejte, da jemljete zdravilo Duloksetin Mylan.
English: Paediatric population Duloxetine has not been studied in patients under the age of 7.
Slovenian: Pediatrična populacija Pri bolnikih, mlajših od 7 let, študij z duloksetinom niso izvedli.
English: • feeling sick (nausea), dry mouth
Slovenian: • občutek slabosti (navzea), suha usta
English: Duloxetine Mylan may be associated with sedation and dizziness.
Slovenian: Zdravilo Duloksetin Mylan je lahko povezano s sedacijo in omotico.
English: During the 52-week placebo-controlled double blind treatment phase 14.4% of the duloxetine-treated patients and 33.1% of the placebo-treated patients experience a return of their depressive symptoms (p<0.001).
Slovenian: V fazi 52-tedenskega s placebom kontroliranega dvojno slepega zdravljenja je povratek simptomov depresije občutilo 14,4 % bolnikov, ki so se zdravili z duloksetinom, in 33,1 % bolnikov, ki so se zdravili s placebom (p < 0,001).
English: As with other serotonergic agents, serotonin syndrome, a potentially life-threatening condition, may occur with duloxetine treatment, particularly with concomitant use of other serotonergic agents (including SSRIs, SNRIs, tricyclic antidepressants or triptans), with agents that impair metabolism of serotonin such as MAOIs, or with antipsychotics or other dopamine antagonists that may affect the serotonergic neurotransmitter systems (see sections 4.3 and 4.5).
Slovenian: Kot pri drugih serotonergičnih zdravilih se lahko tudi pri zdravljenju z duloksetinom pojavi potencialno življenjsko ogrožujoče stanje, še posebej pri sočasni uporabi drugih serotonergičnih zdravil (vključno z SSRI, SNRI, tricikličnimi antidepresivi ali triptani), zdravil, ki vplivajo na presnovo serotonina, na primer zaviralcev MAO, antipsihotikov ali drugih dopaminskih antagonistov, ki lahko vplivajo na serotonergične nevrotransmiterske sisteme (glejte poglavji 4.3 in 4.5).
English: • sudden involuntary jerks or twitches of the muscles, sensation of restlessness or an inability to sit or stand still, feeling nervous, difficulty concentrating, changes in sense of taste, difficulty controlling movement e.g. lack of coordination or involuntary movements of the muscles, restless legs syndrome, poor sleep quality
Slovenian: • nenadni nehoteni gibi mišic ali mišično trzanje, občutek nemira ali nezmožnosti sedenja ali stanja pri miru, živčnost, težave s koncentracijo, spremenjeno okušanje stvari, težave z nadziranjem gibov, npr. slaba koordinacija ali nehoteni gibi mišic, sindrom nemirnih nog, slaba kvaliteta spanja
English: • feeling of dizziness or “spinning” (vertigo), ear pain
Slovenian: • omotica ali vrtoglavica (vertigo), bolečina v ušesih
English: Oral contraceptives and other steroidal agents: Results of in vitro studies demonstrate that duloxetine does not induce the catalytic activity of CYP3A.
Slovenian: Rezultati študij in vitro kažejo, da duloksetin ne inducira katalitske aktivnosti CYP3A.
English: Medicines that increase the level of serotonin: Triptans, tramadol, tryptophan, SSRIs (such as paroxetine and fluoxetine), SNRIs (such as venlafaxine), tricyclic antidepressants (such as clomipramine, amitriptyline), pethidine, St John's Wort and MAOIs (such as moclobemide and linezolid).
Slovenian: Zdravila, ki zvišajo nivo serotonina: Triptani, tramadol, triptofan, SSRI (kot sta paroksetin in fluoksetin), SNRI (kot je venlafaksin), triciklični antidepresivi (kot sta klomipramin, amitriptilin), petidin, šentjanževka in MAOI (kot sta moklobemid in linezolid).
English: Hyponatraemia has been reported when administering Duloxetine Mylan, including cases with serum sodium lower than 110 mmol/l.
Slovenian: Ob dajanju zdravila Duloksetin Mylan so poročali o hiponatriemiji, vključno s primeri, ko je bila serumska koncentracija natrija pod 110 mmol/l.
English: What Duloxetine Mylan looks like and contents of the pack Duloxetine Mylan is hard gastro-resistant capsule.
Slovenian: Izgled zdravila Duloksetin Mylan in vsebina pakiranja Zdravilo Duloksetin Mylan je trda gastrorezistentna kapsula.
English: What you need to know before you take Duloxetine Mylan
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Duloksetin Mylan
English: • dehydration, low levels of sodium in the blood (mostly in elderly people; the symptoms may include feeling dizzy, weak, confused, sleepy or very tired, or feeling or being sick, more serious symptoms are fainting, fits or falls), syndrome of inappropriate secretion of anti-diuretic hormone (SIADH)
Slovenian: • dehidracija, nizka raven natrija v krvi (predvsem pri starejših; simptomi so lahko občutek vrtoglavice, oslabelosti, zmedenosti, zaspanosti ali močne utrujenosti, slabost; resnejši simptomi so lahko omedlevica, epileptični napad ali padci), sindrom nezadostnega izločanja antidiuretičnega hormona (SIADH)
English: Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function (e.g. NSAIDs or acetylsalicylic acid (ASA)), and in patients with known bleeding tendencies.
Slovenian: Pri bolnikih, ki jemljejo zdravila proti strjevanju krvi in/ali druga zdravila, za katera je znano, da vplivajo na delovanje trombocitov (npr. nesteroidne protivnetne učinkovine (NSAID) ali acetilsalicilna kislina (ASA)), ter pri bolnikih z znano nagnjenostjo h krvavitvam je potrebna previdnost.
English: • inflammation of the liver that may cause abdominal pain and yellowing of the skin or whites of the eyes
Slovenian: • vnetje jeter, ki lahko povzroči bolečine v trebuhu in rumeno obarvanje kože ali očesnih beločnic
English: The antibiotic linezolid is a reversible non-selective MAOI and should not be given to patients treated with Duloxetine Mylan (see section 4.4).
Slovenian: Antibiotik linezolid je reverzibilen, neselektiven MAOI in ga bolniki, zdravljeni z zdravilom Duloksetin Mylan, ne smejo prejemati (glejte poglavje 4.4).
English: • abnormal vaginal bleeding, abnormal periods, including heavy, painful, irregular or prolonged periods, unusually light or missed periods, sexual dysfunction, pain in the testicles or scrotum
Slovenian: • neobičajna vaginalna krvavitev, neobičajna menstruacija, vključno z močno, bolečo, neredno ali podaljšano menstruacijo, neobičajna blaga menstruacija ali odsotnost menstruacije, spolna disfunckija, bolečina v modih ali mošnji
English: The incidence of relapse during the 6-months double-blind follow-up period was 14% for duloxetine and 42% for placebo.
Slovenian: Incidenca relapsa v 6-mesečnem obdobju dvojno slepega sledenja je bila 14 % pri prejemnikih duloksetina oziroma 42 % pri prejemnikih placeba.
English: You must wait at least 14 days after you have stopped taking an MAOI before you can take Duloxetine Mylan.
Slovenian: Po prenehanju jemanja MAOI morate počakati vsaj 14 dni, preden lahko vzamete zdravilo Duloksetin Mylan.
English: The usual dose of Duloxetine Mylan is 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Slovenian: Običajen odmerek zdravila Duloksetin Mylan je 60 mg enkrat na dan, za vas ustrezen odmerek pa vam bo predpisal zdravnik.
English: Duloxetine Mylan must not be used in patients with severe renal impairment (creatinine clearance <30 ml/min; see section 4.3).
Slovenian: Zdravila Duloksetin Mylan ne smemo uporabljati pri bolnikih s hudo okvarjenim delovanjem ledvic (očistek kreatinina < 30 ml/min; glejte poglavje 4.3).
English: The study included a 13-week double-blind period where patients were randomised to duloxetine 30 mg/60 mg, or placebo daily.
Slovenian: V študiji s 13-tedenskim dvojno slepim obdobjem so bili bolniki randomizirani na vsakodnevno prejemanje duloksetina 30 mg/60 mg ali placeba.
English: Diabetic Peripheral Neuropathic Pain: The efficacy of duloxetine as a treatment for diabetic neuropathic pain was established in 2 randomised, 12-week, double-blind, placebo-controlled, fixed dose studies in adults (22 to 88 years) having diabetic neuropathic pain for at least 6 months.
Slovenian: Učinkovitost duloksetina kot zdravila za bolečino pri diabetični nevropatiji so ugotavljali v 2 randomiziranih 12-tedenskih dvojno slepih s placebom kontroliranih študijah z določenim odmerkom pri odraslih (starih od 22 do 88 let), ki so imeli bolečino diabetične nevropatije vsaj 6 mesecev.
English: Renal impairment: End stage renal disease (ESRD) patients receiving dialysis had 2-fold higher duloxetine Cmax and AUC values compared with healthy subjects.
Slovenian: Bolniki s končno odpovedjo ledvic v programu dialize so imeli 2-krat višje vrednosti Cmax in AUC duloksetina v primerjavi z zdravimi osebami.
English: Inducers of CYP1A2: Population pharmacokinetic analyses have shown that smokers have almost 50% lower plasma concentrations of duloxetine compared with non-smokers.
Slovenian: Analize populacijske farmakokinetike so pokazale, da imajo kadilci v primerjavi z nekadilci skoraj za 50 % nižje plazemske koncentracije duloksetina.
English: Diabetic Peripheral Neuropathic Pain: As with other medicinal products with similar pharmacological action (antidepressants), isolated cases of suicidal ideation and suicidal behaviours have been reported during duloxetine therapy or early after treatment discontinuation.
Slovenian: Kot pri drugih zdravilih s podobnim farmakološkim delovanjem (antidepresivi) so med zdravljenjem z duloksetinom ali kmalu po prenehanju zdravljenja poročali o posameznih primerih samomorilnih idej in samomorilnega vedenja.
English: The efficacy of duloxetine 30-120 mg (flexible dosing) once a day in elderly patients (>65 years) with generalised anxiety disorder was evaluated in a study that demonstrated statistically significant improvement in the HAM-A total score for duloxetine treated patients compared to placebo treated patients.
Slovenian: Učinkovitost duloksetina 30-120 mg (prilagodljivo odmerjanje) enkrat na dan pri starejših bolnikih (> 65 let) z generalizirano anksiozno motnjo je bila ocenjena v študiji, ki je pokazala statistično pomembno izboljšanje skupnega števila točk po lestvici HAM-A za bolnike, zdravljene z duloksetinom, v primerjavi z bolniki, ki so prejemali placebo.
English: • liver failure, yellowing of the skin or whites of the eyes (jaundice)
Slovenian: • odpoved jeter, rumeno obarvanje kože ali očesnih beločnic (zlatenica)
English: Duloxetine Mylan hard gastro-resistant capsules contain sucrose and sodium.
Slovenian: Duloksetin Mylan trde gastrorezistentne kapsule vsebujejo saharozo in natrij.
English: Other medicines and Duloxetine Mylan
Slovenian: Druga zdravila in zdravilo Duloksetin Mylan
English: • Stevens-Johnson syndrome (serious illness with blistering of the skin, mouth, eyes and genitals),
Slovenian: • Stevens-Johnsonov sindrom (resna bolezen z mehurji na koži, ustih, očeh in genitalijah), resne alergijske reakcije, ki povzročijo otekanje obraza ali grla (angioedem)
English: If you take more Duloxetine Mylan than you should Call your doctor or pharmacist immediately if you take more than the amount of Duloxetine Mylan prescribed by your doctor.
Slovenian: Če ste vzeli večji odmerek zdravila Duloksetin Mylan, kot bi smeli Če vzamete večjo količino zdravila Duloksetin Mylan, kot vam je predpisal zdravnik, nemudoma pokličite zdravnika ali farmacevta.
English: It is therefore advised that duloxetine should be gradually tapered when discontinuing treatment over a period of no less than 2 weeks, according to the patient's needs (see section 4.2).
Slovenian: Zato svetujemo, da se ob prekinjanju zdravljenja v skladu z bolnikovimi potrebami odmerek duloksetina postopoma zmanjšuje v obdobju ne manj kot 2 tednov (glejte poglavje 4.2).
English: DO NOT stop taking your capsules without the advice of your doctor even if you feel better.
Slovenian: Če ste prenehali jemati zdravilo Duloksetin Mylan NE prenehajte jemati svojih kapsul, če vam ni tako svetoval zdravnik, tudi če se počutite bolje.
English: • trouble sleeping, feeling agitated, less sex drive, anxiety, difficulty or failure to experience orgasm,
Slovenian: • težave s spanjem, občutek razdraženosti, manjša želja po spolnosti, nemirnost, težave ali nezmožnost doseči orgazem, nenavadne sanje
English: Breast-feeding mothers: The disposition of duloxetine was studied in 6 lactating women who were at least 12-weeks postpartum.
Slovenian: Odlaganje duloksetina so preučevali pri 6 doječih ženskah v obdobju najmanj 12 tednov po porodu.
English: Duloxetine Mylan 30 mg is available in blister packs of 7, 14, 28, 49, 98 and in a multipack of 98 comprising 2 cartons, each containing 49 capsules, in perforated blister packs containing 7 x1, 28 x 1, 30 x 1 capsules and in bottles containing 30, 100, 250, 500 capsules and a desiccant.
Slovenian: Zdravilo Duloksetin Mylan 30 mg je na voljo v pretisnih omotih s po 7, 14, 28, 49, 98 kapsul in v skupnem pakiranju s po 98 kapsul, sestavljenem iz 2 škatel, vsaka s po 49 kapsul, v perforiranih pretisnih omotih s po 7 x 1, 28 x 1 in 30 x 1 kapsulo in v plastenkah s sušilnim sredstvom s po 30, 100, 250 in 500 kapsulami.
English: 7 hard gastro-resistant capsules 14 hard gastro-resistant capsules 28 hard gastro-resistant capsules 49 hard gastro-resistant capsules 98 hard gastro-resistant capsules 7 x 1 hard gastro-resistant capsules 28 x 1 hard gastro-resistant capsules 30 x 1 hard gastro-resistant capsules
Slovenian: 7 trdih gastrorezistentnih kapsul 14 trdih gastrorezistentnih kapsul 28 trdih gastrorezistentnih kapsul 49 trdih gastrorezistentnih kapsul 98 trdih gastrorezistentnih kapsul 7 x 1 trda gastrorezistentna kapsula 28 x 1 trda gastrorezistentna kapsula 30 x 1 trda gastrorezistentna kapsula
English: Duloxetine Mylan 60 mg
Slovenian: Duloksetin Mylan 60 mg
English: Duloxetine Mylan 60 mg is available in blister packs of 14, 28, 49, 84, 98 and in a multipack of 98 comprising 2 cartons, each containing 49 capsules, in perforated blister packs containing 28 x 1, 30 x 1, and 100 x 1capsules and bottles containing 30, 100, 250 and 500 capsules and a desiccant.
Slovenian: Zdravilo Duloksetin Mylan 60 mg je na voljo v pretisnih omotih s po 14, 28, 49, 84, 98 kapsul in v skupnem pakiranju s po 98 kapsul, sestavljenem iz 2 škatel, vsaka s po 49 kapsul, v perforiranih pretisnih omotih s po 28 x 1, 30 x 1 in 100 x 1 kapsulo in v plastenkah s sušilnim sredstvom s po 30, 100, 250 in 500 kapsulami.
English: Mydriasis has been reported in association with duloxetine, therefore, caution should be used when prescribing Duloxetine Mylan to patients with increased intraocular pressure, or those at risk of acute narrow-angle glaucoma.
Slovenian: V povezavi z duloksetinom so poročali o midriazi, zato je pri predpisovanju zdravila Duloksetin Mylan bolnikom s povišanim intraokularnim tlakom ali s tveganjem za akutni glavkom z zaprtim zakotjem potrebna previdnost.
English: Duloxetine Mylan 30 mg
Slovenian: Duloksetin Mylan 30 mg
English: Duloxetine 60 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.004) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse.
Slovenian: Zdravljenje z duloksetinom 60 mg enkrat na dan se je izkazalo za statistično značilno boljše v primerjavi s placebom (p = 0,004) pri merilu primarnega izida, preprečevanju relapsa depresije, kot so izmerili s časom do relapsa.
English: Duloxetine demonstrated statistical superiority over placebo as measured by improvement in the 17-item Hamilton Depression Rating Scale (HAM-D) total score (including both the emotional and somatic symptoms of depression).
Slovenian: Duloksetin se je izkazal za statistično boljšega kot placebo, kar so izmerili z izboljšanjem skupnega števila točk po Hamiltonovi lestvici za ocenjevanje depresije s 17 postavkami (Hamilton Depression Rating Scale, HAM-D), ki vključuje čustvene in tudi somatske simptome depresije.
English: Effects of other medicinal products on duloxetine Antacids and H2 antagonists: Co-administration of duloxetine with aluminium- and magnesiumcontaining antacids or duloxetine with famotidine had no significant effect on the rate or extent of duloxetine absorption after administration of a 40 mg oral dose.
Slovenian: Sočasno dajanje duloksetina z antacidi, vsebujočimi aluminij in magnezij, ali duloksetina s famotidinom ni imelo pomembnega učinka na hitrost ali obseg absorpcije duloksetina po dajanju 40 mg peroralnega odmerka.
English: Duloxetine demonstrated statistically significant superiority over placebo as measured by improvement in the Hamilton Anxiety Scale (HAM-A) total score and by the Sheehan Disability Scale (SDS) global functional impairment score.
Slovenian: Duloksetin se je izkazal za statistično značilno boljšega kot placebo, kar so izmerili z izboljšanjem skupnega števila točk po Hamiltonovi lestvici za ocenjevanje anksioznosti (Hamilton Anxiety Scale, HAM-A) in s skupnim rezultatom poslabšanja sposobnosti po Sheehanovi lestvici za ocenjevanje nesposobnosti (Sheehan Disability Scale, SDS).
English: Generalised Anxiety Disorder: Duloxetine demonstrated statistically significant superiority over placebo in five out of five studies including four randomised, double-blind, placebo-controlled acute studies and a relapse prevention study in adult patients with generalised anxiety disorder.
Slovenian: Duloksetin se je izkazal za statistično značilno boljšega kot placebo v petih izmed petih študij, vključno s štirimi randomiziranimi, dvojno slepimi, s placebom kontroliranimi akutnimi študijami in študijo preprečevanja relapsa pri odraslih bolnikih z generalizirano anksiozno motnjo.
English: Discontinuation symptoms seen with duloxetine may include hypotonia, tremor, jitteriness, feeding difficulty, respiratory distress and seizures.
Slovenian: Odtegnitveni simptomi, ki so jih opazili pri duloksetinu, lahko vključujejo hipotonijo, tremor, živčnost, probleme s hranjenjem, probleme z dihanjem in epileptične napade.
English: • dizziness, feeling sluggish, tremor, numbness, including numbness, pricking or tingling of the skin
Slovenian: • omotica, občutek nezbranosti, tresenje, otrplost, vključno z otrplostjo, zbadanjem ali mravljinčenjem kože
English: Capsule content: Sugar spheres (sucrose, maize starch), hypromellose, Macrogol, Crospovidone, talc, sucrose, hypromellose phthalate, diethyl phthalate
Slovenian: Vsebina kapsule: sladkorne kroglice (saharoza, koruzni škrob), hipromeloza, makrogol, krospovidon, smukec, saharoza, hipromelozaftalat, dietilftalat.
English: Edible white ink: shellac, propylene glycol, sodium hydroxide, povidone, titanium dioxide (E171).
Slovenian: Užitno belo črnilo: šelak, propilenglikol, natrijev hidroksid, povidon, titanov dioksid (E171).
English: Symptoms of overdose include sleepiness, coma, serotonin syndrome (a rare reaction which may cause feelings of great happiness, drowsiness, clumsiness, restlessness, feeling of being drunk, fever, sweating or rigid muscles), fits, vomiting and fast heart rate.
Slovenian: Simptomi prevelikega odmerka vključujejo zaspanost, komo, serotoninski sindrom (redka reakcija, ki lahko povzroči občutke velike sreče, zaspanost, nerodnost, nemir, občutek pijanosti, vročino, znojenje ali togost mišic), krče, bruhanje in pospešeno bitje srca.
English: Hallucinations Aggression and anger
Slovenian: samomorilno vedenje manija, halucinacije, agresija in jeza